Generate a tailored SOP for Dr. Danny Chou. Improve your application with a focused, well-structured draft.
Danny Hung-Chieh Chou is an Associate Professor in Pediatrics - Endocrinology at Stanford University, with a courtesy appointment in Chemical Systems Biology. He completed his PhD at Harvard University under the guidance of Prof. Stuart Schreiber, focusing on identifying suppressors of cytokine-induced apoptosis in pancreatic beta cells. Following this, he served as a JDRF Postdoctoral Fellow at the Massachusetts Institute of Technology's Department of Chemical Engineering, where he worked on glucose-responsive insulin derivatives. In August 2014, he began an independent career at the University of Utah in the Department of Biochemistry, concentrating on protein and peptide therapeutics for treating Type 1 Diabetes and other human diseases. In 2020, he moved his research lab to Stanford University, continuing to develop innovative insulin therapeutics. His lab has received substantial funding from the NIH, Department of Defense, JDRF, and the American Diabetes Association. Danny has been recognized with several awards including the Early Career Lectureship from the American Peptide Society and the Young Investigator Award from the Boulder Peptide Society.
Stanford University • Stanford, CA
Leading research in pediatrics, focusing on endocrinology, diabetes, and therapeutic development.
University of Utah • Salt Lake City, UT
Focused research on protein and peptide therapeutics for Type 1 Diabetes.
Massachusetts Institute of Technology • Cambridge, MA
Conducted research on glucose-responsive insulin derivatives.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.